Prognostic gene expression signature associated with two molecularly distinct subtypes of colorectal cancer

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Gut

• Publication date

  2011-10-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/gutjnl-2011-300812PMID 21997556PMCID PMC3419333
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• Genetic prognostic and predictive markers in colorectal cancer

  2011cited by this paper
• Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.

  2010influential reference
• The SRC family of protein tyrosine kinases: a new and promising target for colorectal cancer therapy.

  2010cited by this paper
• SRC kinase inhibition: targeting bone metastases and tumor growth in prostate and breast cancer.

  2010cited by this paper
• An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types

  2009cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Evolution of nonsurgical therapy for colorectal cancer

  2009cited by this paper
• Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer

  2009influential reference
• Genetic prognostic and predictive markers in colorectal cancer

  2009cited by this paper
• Mechanisms of the epithelial-mesenchymal transition by TGF-beta.

  2009cited by this paper
• Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.

  2009cited by this paper
• A quantitative multigene RT-PCR assay for prediction of recurrence in stage II colon cancer: Selection of the genes in four large studies and results of the independent, prospectively designed QUASAR validation study.

  2009cited by this paper
• Development of the 21-gene assay and its application in clinical practice and clinical trials.

  2008cited by this paper
• K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

  2008cited by this paper
• Src Continues Aging: Current and Future Clinical Directions

  2007cited by this paper
• Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

  2007cited by this paper
• Analysis of Gene Expression Data Using BRB-Array Tools

  2007cited by this paper
• A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells

  2006cited by this paper
• Stage II colon cancer prognosis prediction by tumor gene expression profiling.

  2006cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Systematic review of microsatellite instability and colorectal cancer prognosis.

  2005cited by this paper
• A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

  2005cited by this paper
• Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway.

  2004cited by this paper
• Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

  2004cited by this paper
• A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

  2004cited by this paper
• Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.

  2004cited by this paper
• American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

  2004cited by this paper
• Osteopontin and colon cancer progression

  2004cited by this paper
• Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling

  2004cited by this paper
• A renaissance for SRC

  2004cited by this paper
• Application of comparative functional genomics to identify best-fit mouse models to study human cancer

  2004cited by this paper
• A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

  2003cited by this paper
• Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

  2003cited by this paper
• Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

  2003cited by this paper
• Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer.

  2003cited by this paper
• Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data

  2002cited by this paper
• A Paradigm for Class Prediction Using Gene Expression Profiles

  2002cited by this paper
• Colorectal cancer.

  1999cited by this paper
• Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)

  1999cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• Transforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients.

  1996cited by this paper
• Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report

  1995cited by this paper
• Microsatellite instability in cancer of the proximal colon.

  1993cited by this paper
• The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.

  1993cited by this paper
• Colorectal cancer

  1993cited by this paper
• Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

  1990cited by this paper
• Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

  1989cited by this paper
• Recurrence rates after curative surgery for rectal carcinoma, with special reference to their accuracy

  1987cited by this paper

• Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials

  2025cites this paper
• Tertiary Lymphoid Structures are Linked to Enhanced Antitumor Immunity and Better Prognosis in Muscle‐Invasive Bladder Cancer

  2024cites this paper
• Integration of expression datasets to identify biomarkers for accurate Gleason scoring in Prostate Cancer

  2024cites this paper
• Transcriptomic Profiling Reveals an Enhancer RNA Signature for Recurrence Prediction in Colorectal Cancer

  2023cites this paper
• A prognostic six‐gene expression risk‐score derived from proteomic profiling of the metastatic colorectal cancer secretome

  2022cites this paper
• Identifying Stage II Colorectal Cancer Recurrence Associated Genes by Microarray Meta-Analysis and Building Predictive Models with Machine Learning Algorithms

  2021cites this paper
• Inferred inactivation of the CFTR gene in the duodena of mice exposed to hexavalent chromium (Cr(VI)) in drinking water supports its tumor-suppressor status and implies its potential role in Cr(VI)-induced carcinogenesis of the small intestines.

  2021cites this paper
• Evaluation of a 55-gene classifier as a prognostic biomarker for adjuvant chemotherapy in stage III colon cancer patients

  2021cites this paper
• Genomic analysis of pancreatic cancer reveals 3 molecular subtypes with different clinical outcomes

  2021cites this paper
• The clinical relevance of gene expression based prognostic signatures in colorectal cancer.

  2021cites this paper
• Silence of Hippo Pathway Associates with Pro-Tumoral Immunosuppression: Potential Therapeutic Target of Glioblastomas

  2020cites this paper
• A 12-immune cell signature to predict relapse and guide chemotherapy for stage II colorectal cancer

  2020cites this paper
• Scoping for RNA biomarkers in colorectal cancer

  2020cites this paper
• Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal Cancer.

  2020cites this paper
• Adjuvant therapy for stages II and III colon cancer: risk stratification, treatment duration, and future directions.

  2019cites this paper
• Molecular Basics on Genitourinary Malignancies

  2019cites this paper
• Statistical Methods for Identifying Biomarkers from miRNA Profiles of Cancers.

  2018cites this paper
• Esophageal squamous cell carcinoma transcriptome reveals the effect of FOXM1 on patient outcome through novel PIK3R3 mediated activation of PI3K signaling pathway

  2018cites this paper
• Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype

  2018cites this paper
• Nomogram Integrating Genomics with Clinicopathologic Features Improves Prognosis Prediction for Colorectal Cancer

  2018cites this paper
• Prognostic Model of Stage II/III Colon Cancer Constructed using Gene Expression Subtypes and KRAS Mutation Status

  2018cites this paper
• Three distinct genomic subtypes of head and neck squamous cell carcinoma associated with clinical outcomes.

  2018cites this paper
• Genomic approach to translational studies in colorectal cancer

  2018cites this paper
• Neoadjuvant chemotherapy affects molecular classification of colorectal tumors

  2017cites this paper
• Prostate cancer molecular profiling: the Achilles heel for the implementation of precision medicine

  2017cites this paper
• Membrane computing inspired feature selection model for microarray cancer data

  2017cites this paper
• Recurrence‐associated gene signature optimizes recurrence‐free survival prediction of colorectal cancer

  2017influential citation
• Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project

  2017cites this paper
• From tumour heterogeneity to advances in precision treatment of colorectal cancer

  2017cites this paper
• Gene signatures associated with drug resistance to irinotecan and oxaliplatin predict a poor prognosis in patients with colorectal cancer

  2017cites this paper
• Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers

  2017cites this paper
• Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages

  2016cites this paper
• multiClust: An R-package for Identifying Biologically Relevant Clusters in Cancer Transcriptome Profiles

  2016cites this paper
• Translating colorectal cancer genetics into clinically useful biomarkers

  2016cites this paper
• Predicting prognosis and therapy response in CRC patients

  2016cites this paper
• Adjuvant Systemic Therapy in Stage II and III Colon Cancer

  2016cites this paper
• Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer.

  2016cites this paper
• Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer

  2016cites this paper
• Are Gene Signatures Ready for Use in the Selection of Patients for Adjuvant Treatment?

  2016cites this paper
• Identification of upstream regulators for synovial expression signature genes in osteoarthritis.

  2016cites this paper
• Pregnane X-receptor promotes stem cell-mediated colon cancer relapse

  2016cites this paper
• CFTR is a tumor suppressor gene in murine and human intestinal cancer

  2016cites this paper
• Evaluation of frozen tissue-derived prognostic gene expression signatures in FFPE colorectal cancer samples

  2016cites this paper
• CFTR is a tumor suppressor gene in murine and human intestinal cancer.

  2016cites this paper
• Colon cancer subtypes: concordance, effect on survival and selection of the most representative preclinical models

  2016cites this paper
• Gene signatures of estrogen and progesterone receptor pathways predict the prognosis of colorectal cancer

  2016cites this paper
• CFTR is a potential marker for nasopharyngeal carcinoma prognosis and metastasis

  2016cites this paper
• A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome

  2015cites this paper
• Inactivation of Hippo Pathway Is Significantly Associated with Poor Prognosis in Hepatocellular Carcinoma

  2015cites this paper
• CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer

  2015cites this paper
• Identifying molecular subtypes in human colon cancer using gene expression and DNA methylation microarray data

  2015cites this paper
• Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach

  2015cites this paper
• A 12‐gene signature to distinguish colon cancer patients with better clinical outcome following treatment with 5‐fluorouracil or FOLFIRI

  2015cites this paper
• Elucidating the molecular aspects of colorectal cancer and their clinical importance

  2015cites this paper
• Stromal contribution to the colorectal cancer transcriptome

  2015cites this paper
• Intrinsic cancer subtypes-next steps into personalized medicine

  2015cites this paper
• Prognosis and Therapeutic Implications for Emerging Colorectal Cancer Subtypes

  2014cites this paper
• Management of colorectal cancer

  2014cites this paper
• Significant Association of Oncogene YAP1 with Poor Prognosis and Cetuximab Resistance in Colorectal Cancer Patients

  2014cites this paper
• Exploring mechanisms of diet-colon cancer associations through candidate molecular interaction networks

  2014influential citation
• A nineteen gene‐based risk score classifier predicts prognosis of colorectal cancer patients

  2014cites this paper
• Title Exploring mechanisms of diet-colon cancer associationsthrough candidate molecular interaction networks

  2014influential citation
• Estudios farmacogenéticos en el cáncer colorrectal: la vía del receptor del factor de crecimiento epidérmico

  2014cites this paper
• Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.

  2014influential citation
• Unsupervised analyses reveal molecular subtypes associated to prognosis and response to therapy in colorectal cancer

  2014cites this paper
• Molecular and Cellular Pathobiology Nuclear Factor of Activated T-cell Activity Is Associated with Metastatic Capacity in Colon Cancer

  2014cites this paper
• Re: test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.

  2014cites this paper
• Anticipating the Clinical Use of Prognostic Gene Expression–Based Tests for Colon Cancer Stage II and III: Is Godot Finally Arriving?

  2013cites this paper
• Computational evaluation of cellular metabolic costs successfully predicts genes whose expression is deleterious

  2013cites this paper
• [Perspectives of the stomach cancer treatment: the introduction of molecular targeted therapy and the hope for cure].

  2013cites this paper
• Comparison of Prognostic Genomic Predictors in Colorectal Cancer

  2013influential citation
• Identification of upstream regulators for prognostic expression signature genes in colorectal cancer

  2013influential citation
• Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma

  2013cites this paper
• Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition

  2013cites this paper
• Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value

  2013cites this paper
• Valeur pronostique et prédictive des signatures moléculaires dans les cancers colo-rectaux

  2013cites this paper
• Combining clinicopathological and molecular pathway signatures for improving clinical decisions through an understanding of colorectal cancer biology

  2013cites this paper
• A Network-Based Gene Expression Signature Informs Prognosis and Treatment for Colorectal Cancer Patients

  2012cites this paper
• Defining new criteria for selection of cell-based intestinal models using publicly available databases

  2012cites this paper
• Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines

  2012influential citation
• Development and Validation of a Prognostic Gene-Expression Signature for Lung Adenocarcinoma

  2012cites this paper
• Distributed under Creative Commons Cc-by 4.0 Colofinder: a Prognostic 9-gene Signature Improves Prognosis for 871 Stage Ii and Iii Colorectal Cancer Patients

  year unknowncites this paper